Table 30 Aripiprazole for children and adolescents with Anorexia Nervosa
From: Canadian practice guidelines for the treatment of children and adolescents with eating disorders
Certainty assessment | Impact | Certainty | Importance | ||||||
|---|---|---|---|---|---|---|---|---|---|
№ of studies | Study design | Risk of bias | Inconsistency | Indirectness | Imprecision | Other considerations | |||
Weight | |||||||||
1 | Case Control | serious a | not serious | not serious | not serious | none | Retrospective case-control study with 22 subjects treated with aripiprazole, 84 no treatment. BMI was slightly different between groups 18.8 vs. 17.9 p < 0.35. | ⨁◯◯◯ VERY LOW | CRITICAL |
Weight | |||||||||
2 | Case Reports | very serious a,b | not serious | not serious | not serious | none | 5 cases report a benefit in terms of weight gain | ⨁◯◯◯ VERY LOW | CRITICAL |